We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Invex Therapeutics Ltd is a biotechnology business based in Australia. Invex Therapeutics shares (IXC) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Invex Therapeutics has a trailing 12-month revenue of around $158,785. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.51 - $1.075 |
|---|---|
| 50-day moving average | $0.6777 |
| 200-day moving average | $0.6938 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.03 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.68
| 1 week (2021-11-22) | 8.80% |
|---|---|
| 1 month (2021-10-29) | 3.82% |
| 3 months (2021-08-27) | -7.48% |
| 6 months (2021-05-28) | 0.68 |
| 1 year (2020-11-27) | -15.53% |
|---|---|
| 2 years (2019-11-29) | -10.53% |
| Revenue TTM | $158,785 |
|---|---|
| Gross profit TTM | $158,785 |
| Return on assets TTM | -5.16% |
| Return on equity TTM | -8.09% |
| Profit margin | 0% |
| Book value | 0.427 |
| Market capitalisation | $51.1 million |
TTM: trailing 12 months
We're not expecting Invex Therapeutics to pay a dividend over the next 12 months.
Over the last 12 months, Invex Therapeutics 's shares have ranged in value from as little as $0.51 up to $1.075. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Invex Therapeutics 's is 1.0845. This would suggest that Invex Therapeutics 's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 2019 and is headquartered in Subiaco, Australia.
Black Friday has landed, which means its time to get a deal on some fancy tech, from phones and headphones to laptops and cameras.
Black Friday's best Christmas shopping deals for kids include Lego for 40% off, 38% off Beyblade, LEGO bargains galore and big Bluey discounts
Setting a goal of making $200k per year passive income may seem all but unattainable, but investing experts Scott & Mina O'Neill say it's possible.
Come for the football, stay for the quality original TV.
In spite of the recent crash which saw nearly AU $400 billion being wiped out from the market, ETH has been able to register monthly gains of over 6%.
Over the course of the last 14 days, Bitcoin has registered losses of over 16%.
Top Black Friday iPhone deals include 26% off the iPhone 12 Mini at The Good Guys and cut-price refurbished models at Amazon and eBay.
The best Black Friday 2021 discounts include over $1,000 off 75-inch and 85-inch smart TVs from Samsung and Hisense.
We've handpicked the 50 best Black Friday deals available in Australia right now, including tech favourites, games, toys, beauty, homewares and more.
We've handpicked the 50 best Black Friday deals available from eBay right now, including tech, games, home appliances and more.
